GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Betta Pharmaceuticals Co Ltd (SZSE:300558) » Definitions » Price-to-Free-Cash-Flow

Betta Pharmaceuticals Co (SZSE:300558) Price-to-Free-Cash-Flow : 69.10 (As of Mar. 04, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Betta Pharmaceuticals Co Price-to-Free-Cash-Flow?

As of today (2025-03-04), Betta Pharmaceuticals Co's share price is ¥51.27. Betta Pharmaceuticals Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 was ¥0.74. Hence, Betta Pharmaceuticals Co's Price-to-Free-Cash-Flow Ratio for today is 69.10.

The historical rank and industry rank for Betta Pharmaceuticals Co's Price-to-Free-Cash-Flow or its related term are showing as below:

SZSE:300558' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 58.03   Med: 188.54   Max: 819.01
Current: 69.1

During the past 13 years, Betta Pharmaceuticals Co's highest Price-to-Free-Cash-Flow Ratio was 819.01. The lowest was 58.03. And the median was 188.54.

SZSE:300558's Price-to-Free-Cash-Flow is ranked worse than
81.29% of 529 companies
in the Drug Manufacturers industry
Industry Median: 24.06 vs SZSE:300558: 69.10

Betta Pharmaceuticals Co's Free Cash Flow per Share for the three months ended in Sep. 2024 was ¥0.38. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ¥0.74.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was -64.20% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -17.30% per year.

During the past 13 years, Betta Pharmaceuticals Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 49.60% per year. The lowest was -119.10% per year. And the median was -13.10% per year.


Betta Pharmaceuticals Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Betta Pharmaceuticals Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Betta Pharmaceuticals Co Price-to-Free-Cash-Flow Chart

Betta Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Betta Pharmaceuticals Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 80.77 61.95

Competitive Comparison of Betta Pharmaceuticals Co's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Betta Pharmaceuticals Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Betta Pharmaceuticals Co's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Betta Pharmaceuticals Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Betta Pharmaceuticals Co's Price-to-Free-Cash-Flow falls into.



Betta Pharmaceuticals Co Price-to-Free-Cash-Flow Calculation

Betta Pharmaceuticals Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=51.27/0.742
=69.10

Betta Pharmaceuticals Co's Share Price of today is ¥51.27.
Betta Pharmaceuticals Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.74.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Betta Pharmaceuticals Co  (SZSE:300558) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Betta Pharmaceuticals Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Betta Pharmaceuticals Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Betta Pharmaceuticals Co Business Description

Traded in Other Exchanges
N/A
Address
No. 355, Xingzhong Road, Economic and Technological Development Zone, Yuhang District, Zhejiang Province, Hangzhou, CHN, 311100
Betta Pharmaceuticals Co Ltd is a pharmaceutical enterprise that focuses on the research and development of innovative medicines. The company's drug is used for various diseases such as malignant tumors, diabetes, and cardio-cerebrovascular disease. Further, it offers Icotinib hydrochloride, an orally administered small-molecule and a reversible tyrosine kinase inhibitor, which is used for the treatment of non-small-cell lung cancer. Geographically, the group operates in China.
Executives
Wang Jia Bing Directors, executives
Ding Lie Ming Directors, executives
Cai Wan Yu Executives

Betta Pharmaceuticals Co Headlines

No Headlines